We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DUK:NYSEDuke Energy Corporation (Holding Company) Analysis

Data as of 2026-03-09 - not real-time

$131.08

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

DUK delivered an earnings beat and posted a noticeable increase in earnings per share for the year, while unveiling an ambitious multi‑billion‑dollar capital plan that underscores its growth ambitions. Technical indicators are broadly supportive: the short‑term moving average sits above the medium and long‑term averages, the MACD line remains above its signal, and the RSI is in the upper half of its range but not yet overbought. The stock trades at a premium to its discounted cash‑flow estimate, suggesting a modest overvaluation, yet it offers a solid dividend yield that is attractive for income‑focused investors.
The utility sector’s defensive nature, combined with a near‑zero beta and moderate 30‑day volatility, points to a low‑risk profile. Regulatory risk is present but manageable given the company’s regulated revenue base, and the geographic exposure is largely confined to the United States, limiting currency concerns. Overall, the blend of stable cash flows, attractive dividend, and ongoing growth initiatives supports a cautiously optimistic outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical momentum but limited near‑term upside
  • Attractive dividend income
  • Current price slightly above fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent earnings growth and capital investment plan
  • Sustained dividend payout with reasonable coverage
  • Regulated revenue providing earnings stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive utility positioning with low market correlation
  • Long‑term growth prospects from infrastructure expansion
  • Reliable cash flow generation supporting dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth8.00%
Profit Margin15.63%
P/E Ratio20.8
ROE9.72%
ROA2.81%
Debt/Equity171.84
P/B Ratio2.0
Op. Cash Flow$12.3B
Free Cash Flow$-2002625024
Industry P/E20.8

Technical Analysis

TrendBullish
RSI66.7
Support$120.46
Resistance$132.66
MA 20$128.27
MA 50$122.60
MA 200$121.31
MACDBullish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$99.17
Target Price$137.13
Upside/Downside4.61%
GradeOvervalued
TypeBlend
Dividend Yield3.22%

Risk Assessment

Beta-0.05
Volatility14.26%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.